DMD and Duchenne muscular dystrophy: In clinical trials for DMD, micro-dystrophin delivered by rAAVrh74 has persisted for over 3 years [98], and for spinal muscular atrophy, survival motor neuron delivered by AAV9 has proven efficacious for over 5 years [99].